Powered by MOMENTUM MEDIA
lawyers weekly logo
Advertisement
Markets
10 September 2025 by Adrian Suljanovic

Are big banks entering a new cost-control cycle?

Australia’s biggest banks have axed thousands of jobs despite reporting record profits over the year, fuelling concerns over cost-cutting, offshoring ...
icon

How $2.68tn is spread across products and investments

Australia’s $2.68 trillion superannuation system is being shaped not only by the dominance of MySuper and Choice ...

icon

Private credit growth triggers caution at Yarra Capital

As private credit emerges as a fast-growing asset class, Yarra Capital Management remains cautious about the risks that ...

icon

CBA flags end of global rate-cutting cycle

The major bank has indicated that central banks are nearing the end of their rate-cutting cycles, while Trump’s pressure ...

icon

ETF market nears $300bn as international equities lead inflows

The Australian ETF industry is on the cusp of hitting $300 billion in assets under management, with VanEck forecasting ...

icon

Lonsec joins Count in raising doubts over Metrics funds

Lonsec has cut ratings on three Metrics Credit Partners funds, intensifying scrutiny on the private credit manager’s ...

VIEW ALL

Lazard picks up Catholic mandate

  •  
By Christine St Anne
  •  
2 minute read

A Catholic industry superannuation fund has added more money to its emerging market mandate.

Industry fund, the Catholic Superannuation and Retirement Fund (CSRF) has doubled its investment in emerging markets.

The asset class now represents six per cent of the fund's investment portfolio. The mandate will be managed by the fund's existing manager Lazard.

The investment changers were a result of the fund's review of its $1 billion international equities portfolio.

"We see regular reviews of our investments in all markets and asset classes as an essential part of ensuring we are making our members' money work hardest for them," CSRF chief executive Greg Cantor said.

 
 

The fund's international equity managers include Alliance, Barclays Global Investors, Credit Suisse and GMO.